Shenyang EverBright Pharmaceutical Co., Ltd.
-
Founded in:
1999-01-22 -
Country:
China -
Address:
No. 31, Songhuahu Street, Shenyang Economic and Technological Development Zone -
Tax NO.:
912101064107084581 -
Registered Funds:
8.82 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| RNA extracted from the liver, spleen, lymph nodes and other lymphatic tissues of sheep (cattle) |
Tumor-specific immunotherapy drugs can transfer the donor's specific immune response ability to the patient's lymphocytes, thereby enhancing the body's specific humoral and cellular immune response to lung cancer; they also have the ability to mediate cytotoxic effects.
More
Tumor-specific immunotherapy drugs can transfer the donor's specific immune response ability to the patient's lymphocytes, thereby enhancing the body's specific humoral and cellular immune response to lung cancer; they also have the ability to mediate cytotoxic effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| RNA extracted from the liver, spleen, lymph nodes and other lymphatic tissues of sheep (cattle) |
It is a tumor-specific immunotherapy drug that can transfer the donor's specific immune response ability to the patient's lymphocytes, thereby enhancing the body's specific humoral and cellular immune response to lung cancer; it also has the ability to mediate cytotoxic effects.
More
It is a tumor-specific immunotherapy drug that can transfer the donor's specific immune response ability to the patient's lymphocytes, thereby enhancing the body's specific humoral and cellular immune response to lung cancer; it also has the ability to mediate cytotoxic effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anti-HBV immune RNA |
The specific pharmacological effect is not clear from the information
More
The specific pharmacological effect is not clear from the information |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Omeprazole sodium |
This product is a proton pump inhibitor of gastric parietal cells, which can specifically inhibit the secretory microtubules and H, K-ATPases on the tubular vesicles in the cytoplasm of the parietal cell apical membrane, thereby effectively inhibiting the secretion of gastric acid. It can not only non-competitively inhibit the gastric acid secretion caused by gastrin, histamine, choline, food, and stimulation of the vagus nerve, but also inhibit part of the basic gastric acid secretion that is not affected by choline or H2 receptor blockers. It also has a strong and lasting inhibitory effect on the gastric acid secretion caused by dibutyl cyclic adenosine monophosphate (DCAMP) stimulation that cannot be inhibited by H2 receptor antagonists. In addition, this product also has an inhibitory effect on the secretion of pepsin, has no obvious change in gastric mucosal blood flow, and does not affect body temperature, gastric cavity temperature, arterial blood pressure, venous hemoglobin, arterial oxygen partial pressure, carbon dioxide partial pressure and arterial blood pH.
More
This product is a proton pump inhibitor of gastric parietal cells, which can specifically inhibit the secretory microtubules and H, K-ATPases on the tubular vesicles in the cytoplasm of the parietal cell apical membrane, thereby effectively inhibiting the secretion of gastric acid. It can not only non-competitively inhibit the gastric acid secretion caused by gastrin, histamine, choline, food, and stimulation of the vagus nerve, but also inhibit part of the basic gastric acid secretion that is not affected by choline or H2 receptor blockers. It also has a strong and lasting inhibitory effect on the gastric acid secretion caused by dibutyl cyclic adenosine monophosphate (DCAMP) stimulation that cannot be inhibited by H2 receptor antagonists. In addition, this product also has an inhibitory effect on the secretion of pepsin, has no obvious change in gastric mucosal blood flow, and does not affect body temperature, gastric cavity temperature, arterial blood pressure, venous hemoglobin, arterial oxygen partial pressure, carbon dioxide partial pressure and arterial blood pH. |
95510-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Anti-HBV immune RNA |
The specific pharmacological effect is not clear from the information
More
The specific pharmacological effect is not clear from the information |
0 |